Rima Rozen

Dr. Rima Rozen


Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2001 in American Journal of PharmacoGenomics
Verified
Journal Article
Closed access
PDF file
BSBernd Schwahn
Bernd Schwahn
RRRima Rozen
Rima Rozen

1 March 2015 in The American Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
KCKaren E Christensen
Karen E Christensen
LMLeonie G Mikael
Leonie G Mikael
KLKit-Yi Leung
Kit-Yi Leung
NLNancy Lévesque
Nancy Lévesque
LDLiyuan Deng
Liyuan Deng
RRRima Rozen
Rima Rozen
Background: Increased consumption of folic acid is prevalent, leading to concerns about negative consequences. The effects of folic acid on the liver,

22 January 2003 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
BSBernd C. Schwahn
Bernd C. Schwahn
ZCZhoutao Chen
Zhoutao Chen
MLMaurice D. Laryea
Maurice D. Laryea
UWUdo Wendel
Udo Wendel
SLSuzanne Lussier‐Cacan
Suzanne Lussier‐Cacan
RRRima Rozen
Rima Rozen
Hyperhomocysteinemia, a proposed risk factor for cardiovascular disease, is also observed in other common disorders. The most frequent genetic cause of hyperhomocysteinemia is a mutated methylenetetrahydrofolate reductase (MTHFR), predominantly when folate status is impaired. MTHFR synthesizes a major methyl donor for homocysteine remethylation to methionine. We administered the alternate choline‐derived methyl donor, betaine, to wild‐type mice and to littermates with mild or severe hyperhomocysteinemia due to hetero‐ or homozygosity for a disruption of the Mthfr gene. On control diets, plasma homocysteine and liver choline metabolite levels were strongly dependent on the Mthfr genotype. Betaine supplementation decreased homocysteine in all three genotypes, restored liver betaine and phosphocholine pools, and prevented severe steatosis in Mthfr ‐deficient mice. Increasing betaine intake did not further decrease homocysteine. In humans with cardiovascular disease, we found a significant negative correlation between plasma betaine and homocysteine concentrations. Our results emphasize the strong interrelationship between homocysteine, folate, and choline metabolism. Hyperhomocysteinemic Mthfr ‐compromised mice appear to be much more sensitive to changes of choline/betaine intake than do wild‐type animals. Hyperhomocysteinemia, in the range of that associated with folate deficiency or with homozygosity for the 677T MTHFR variant, may be associated with disturbed choline metabolism.

16 February 2017 in British Journal of Cancer
Verified
Journal Article
Open access
PDF file
DLD Leclerc
D Leclerc
DPD N T Pham
D N T Pham
NLN Lévesque
N Lévesque
MTM Truongcao
M Truongcao
WFW D Foulkes
W D Foulkes
RRRima Rozen
Rima Rozen
Cancer cells maintain high rates of glycolysis. Pyruvate dehydrogenase kinases (PDK) contribute to this phenomenon, which favours apoptosis resistance and cellular transformation. We previously reported upregulation of PDK4 in normal mucosa of colorectal cancer (CRC) patients compared with controls and in preneoplastic intestine of our mouse model. Decreased methylation of four consecutive PDK4 CpGs was observed in normal mucosa of patients. Although other members of the PDK family have been investigated for transformation potential, PDK4 has not been extensively studied. PDK4 methylation in blood of CRC patients and controls was evaluated by pyrosequencing. PDK4 expression in human colon carcinoma cells was down-regulated by RNAi. Cellular migration and invasion, apoptosis and qRT-PCR of key genes were assessed. Pyrosequencing revealed decreased methylation of the same four consecutive CpGs in the blood of patients compared with controls. Cellular migration and invasion were reduced and apoptosis was increased following transient or stable inhibition of PDK4. Expression of vimentin, HIF-1 and VEGFA was reduced. These studies demonstrate the involvement of PDK4 in transformation. Methylation assessment of PDK4 in the blood may be useful for non-invasive CRC detection. PDK4 should be considered as a target for development of anticancer strategies and therapies

22 December 2010 in Birth Defects Research Part A: Clinical and Molecular Teratology
Verified
Journal Article
Closed access
PDF file
LPLaura Pickell
Laura Pickell
KBKatharine Brown
Katharine Brown
DLDeqiang Li
Deqiang Li
XWXiao‐Ling Wang
Xiao‐Ling Wang
LDLiyuan Deng
Liyuan Deng
RRRima Rozen
Rima Rozen